Skip to content
Clinical Trials – home

Oxybuprocaine Hydrochloride: A Comprehensive Guide for Patients

5 / 5
trials open to patients / all trials
9+
Countries

In short

Oxybuprocaine Hydrochloride, also known as benoxinate, is a local anesthetic commonly used in ophthalmology. This article explores its application in various clinical trials, focusing on its effectiveness in reducing pain and discomfort during ocular procedures. We'll examine how this drug is being studied for different eye-related conditions and surgical interventions.

At a glance

Primary Uses
Topical anesthesia for eye procedures, pain reduction in ROP screening, ocular surface anesthesia for various examinations and surgeries
Formulation
Typically used as 0.4% eye drops, sometimes in preservative-free unit-dose vials
Comparative Studies
Being compared to other anesthetics like Chloroprocaine and artificial tears in various trials
Patient Groups
Studied in premature infants, pediatric patients, and adults undergoing different eye procedures
Outcome Measures
Pain scores (PIPP, VAS), patient comfort, surgeon satisfaction, corneal healing time, endothelial cell density
Safety Considerations
Effects on corneal healing, potential impact on endothelial cells, short-term vs. long-term use safety

What is Oxybuprocaine Hydrochloride?

Oxybuprocaine Hydrochloride is a type of medication known as a local anesthetic. It's primarily used in eye care to numb the surface of the eye temporarily. This drug is also known by other names, including Benoxinate and Benox. The medication typically comes in the form of eye drops, usually in a 0.4% concentration.

Medical Uses

Oxybuprocaine Hydrochloride is used in various eye-related medical procedures and conditions:

  • Retinopathy of Prematurity (ROP) Screening: It's used to reduce pain in premature infants during eye examinations for ROP, a condition that can affect the eyes of premature babies.
  • Cataract Surgery: The medication is used to provide topical anesthesia (numbing of the eye surface) during cataract operations.
  • Ocular Examinations: It's used to numb the eye for various types of eye exams that might be uncomfortable without anesthesia.
  • Laser Eye Surgery: Oxybuprocaine is used as an anesthetic during procedures like SMILE (Small Incision Lenticule Extraction) for correcting myopia (short-sightedness).

How is it Administered?

Oxybuprocaine Hydrochloride is typically administered as eye drops. The exact dosage and frequency can vary depending on the specific procedure or condition being treated. Here are some examples:

  • For cataract surgery, it may be instilled twice, 5 minutes apart, before the procedure.
  • In some studies, it's given as two drops, one minute apart, before an eye examination.
  • For laser eye surgery, it's used as an anesthetic during the procedure.

It's important to note that this medication should only be administered by or under the supervision of a healthcare professional. Patients should not attempt to use this medication at home unless specifically instructed by their doctor.

Current Clinical Trials

Several clinical trials are currently investigating the use of Oxybuprocaine Hydrochloride:

  • A study is looking at its effectiveness in reducing pain during ROP screening in premature infants.
  • Another trial is comparing it to a gel form of another anesthetic (Chloroprocaine) for pediatric eye exams.
  • Researchers are also studying its effects on the eye's microbial environment when used during examinations.

Potential Side Effects and Safety

While Oxybuprocaine Hydrochloride is generally considered safe when used as directed by a healthcare professional, it can have some side effects. These may include:

  • Temporary stinging or burning sensation when applied
  • Potential changes to the eye's microbial environment (the natural balance of microorganisms on the eye's surface)

It's important to note that the safety of long-term or frequent use of topical anesthetics on the eye is still being studied. In one trial, researchers are investigating whether short-term use of preservative-free topical anesthetics after certain eye surgeries is safe for the cornea (the clear front part of the eye).

Alternatives and Comparisons

While Oxybuprocaine Hydrochloride is widely used, there are other options for eye anesthesia:

  • Chloroprocaine: A study is comparing a gel form of this anesthetic to Oxybuprocaine eye drops for pediatric eye exams.
  • Proxymetacaine: This is another type of eye drop anesthetic sometimes used in combination with Oxybuprocaine.
  • Benoxinate: This is actually another name for Oxybuprocaine, so it's the same medication.

The choice of anesthetic depends on various factors, including the specific procedure, the patient's age and health condition, and the doctor's preference. Your eye care professional will determine the most appropriate option for your specific situation.

Questions people often ask

Conditions where Oxybuprocaine Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Oxybuprocaine Hydrochloride

Recruiting trials first

See all 5 →
Quick filters
  • Participants:Adults
  • Participants:Children
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).